Target intelligence / Profile preview

microRNA 3690 (MIR3690)

Target
MIR3690
Molecular classification
MicroRNA, Non-coding RNA, Other
01

Overview

MicroRNA 3690 is a short, single-stranded non-coding RNA of 20-24 nucleotides. It functions as a post-transcriptional regulator of gene expression by binding to the 3′ untranslated regions (UTRs) of target messenger RNAs, leading to translational repression or mRNA degradation. MIR3690 is upregulated in human thyroid cancer, where it acts as an oncogene by promoting cell proliferation, colony formation, and cell cycle progression through suppression of Dickkopf-related protein 3 (DKK3). Elevated levels of MIR3690 are associated with increased expression of cyclin E and c-myc, facilitating transition from G1 to S phase in the cell cycle. MIR3690 is being evaluated as a potential biomarker and therapeutic target in oncology.

Other names
MIR3690MIR3690-1MIR3690-2hsa-mir-3690-1hsa-mir-3690-2microRNA 3690-1microRNA 3690-2mir-3690-1mir-3690-2hsa-mir-3690
02

Mechanism of action

Antisense inhibition (experimental approach using anti-miR-3690 oligonucleotides); Downregulation of oncogenic targets by diminishing MIR3690 activity (preclinical evidence)

03

Biological functions

Post-transcriptional gene regulationCell cycle progressionCell proliferation
04

Disease associations

Cancer (specifically thyroid cancer)Potentially other cancers (by analogy to functions outlined in general microRNA literature)
05

Safety considerations

Off-target effects typical of RNA-targeting therapiesPotential cell cycle disruption in normal tissues (inferred from biological role)
06

Biomarkers

Upregulation of MIR3690 in thyroid cancer tissues and cell lines indicates its potential as a biomarker for diagnosis or stratification

Beyond the preview

Go deeper on microRNA 3690 (MIR3690).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 3690 (MIR3690).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call